+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Mycoplasma Testing Global Market Report 2021: COVID-19 Growth and Change

  • ID: 5360322
  • Report
  • July 2021
  • Region: Global
  • 175 pages
  • The Business Research Company

FEATURED COMPANIES

  • Abbott
  • ARTWORKSIT
  • Clongen Laboratories LLC
  • GenBio
  • Lonza
  • Mycoplasma Experience
Mycoplasma Testing Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global mycoplasma testing market.

This report focuses on mycoplasma testing market which is experiencing strong growth. The report gives a guide to the mycoplasma testing market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the mycoplasma testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Mycoplasma Testing market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider mycoplasma testing market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The mycoplasma testing market section of the report gives context. It compares the mycoplasma testing market with other segments of the mycoplasma testing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, mycoplasma testing indicators comparison.
Scope

Markets Covered:

1) By Product: Instruments; Assay, Kits, and Reagents
2) By Technology: PCR; ELISA; Enzymatic Methods; DNA Staining; Other Technologies
3) By Application: Cell line Testing; Virus Testing; End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies; Cell Banks & Laboratories; Contract Research Organizations; Academic Research Institutes

Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza; PromoCell GmbH; American Type Culture Collection

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • ARTWORKSIT
  • Clongen Laboratories LLC
  • GenBio
  • Lonza
  • Mycoplasma Experience
1. Executive Summary

2. Mycoplasma Testing Market Characteristics

3. Mycoplasma Testing Market Trends and Strategies

4. Impact Of COVID-19 On Mycoplasma Testing

5. Mycoplasma Testing Market Size and Growth
5.1. Global Mycoplasma Testing Historic Market, 2015-2020, Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Mycoplasma Testing Forecast Market, 2020-2025F, 2030F, Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Mycoplasma Testing Market Segmentation
6.1. Global Mycoplasma Testing Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
  • Instruments
  • Assay, Kits, and Reagents
6.2. Global Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
  • PCR
  • ELISA
  • Enzymatic Methods
  • DNA Staining
  • Other Technologies
6.3. Global Mycoplasma Testing Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
  • Cell line Testing
  • Virus Testing
  • End- of- Production Cell Testing
6.4. Global Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
  • Pharmaceutical & Biotechnology Companies
  • Cell Banks & Laboratories
  • Contract Research Organizations
  • Academic Research Institutes
7. Mycoplasma Testing Market Regional and Country Analysis
7.1. Global Mycoplasma Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
7.2. Global Mycoplasma Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

8. Asia-Pacific Mycoplasma Testing Market
8.1. Asia-Pacific Mycoplasma Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
8.3. Asia-Pacific Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

9. China Mycoplasma Testing Market
9.1. China Mycoplasma Testing Market Overview
9.2. China Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Mycoplasma Testing Market
10.1. India Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
10.2. India Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

11. Japan Mycoplasma Testing Market
11.1. Japan Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
11.2. Japan Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

12. Australia Mycoplasma Testing Market
12.1. Australia Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
12.2. Australia Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

13. Indonesia Mycoplasma Testing Market
13.1. Indonesia Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
13.2. Indonesia Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

14. South Korea Mycoplasma Testing Market
14.1. South Korea Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
14.2. South Korea Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

15. Western Europe Mycoplasma Testing Market
15.1. Western Europe Mycoplasma Testing Market Overview
15.2. Western Europe Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
15.3. Western Europe Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

16. UK Mycoplasma Testing Market
16.1. UK Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
16.2. UK Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

17. Germany Mycoplasma Testing Market
17.1. Germany Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
17.2. Germany Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

18. France Mycoplasma Testing Market
18.4. France Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
18.5. France Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

19. Eastern Europe Mycoplasma Testing Market
19.1. Eastern Europe Mycoplasma Testing Market Overview
19.2. Eastern Europe Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
19.3. Eastern Europe Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

20. Russia Mycoplasma Testing Market
20.1. Russia Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
20.2. Russia Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

21. North America Mycoplasma Testing Market
21.1. North America Mycoplasma Testing Market Overview
21.2. North America Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
21.3. North America Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

22. USA Mycoplasma Testing Market
22.1. USA Mycoplasma Testing Market Overview
22.2. USA Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
22.3. USA Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

23. South America Mycoplasma Testing Market
23.1. South America Mycoplasma Testing Market Overview
23.2. South America Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
23.3. South America Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

24. Brazil Mycoplasma Testing Market
24.1. Brazil Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
24.2. Brazil Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

25. Middle East Mycoplasma Testing Market
25.1. Middle East Mycoplasma Testing Market Overview
25.2. Middle East Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
25.3. Middle East Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

26. Africa Mycoplasma Testing Market
26.1. Africa Mycoplasma Testing Market Overview
26.2. Africa Mycoplasma Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion
26.3. Africa Mycoplasma Testing Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Billion

27. Mycoplasma Testing Market Competitive Landscape and Company Profiles
27.1. Mycoplasma Testing Market Competitive Landscape
27.2. Mycoplasma Testing Market Company Profiles
27.2.1. Thermo Fisher Scientific Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Merck KGaA
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Lonza
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. PromoCell GmbH
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. American Type Culture Collection
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Key Mergers and Acquisitions In The Mycoplasma Testing Market

29. Mycoplasma Testing Market Future Outlook and Potential Analysis

30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • ARTWORKSIT
  • Clongen Laboratories LLC
  • GenBio
  • Lonza
  • Mycoplasma Experience
Major players in the mycoplasma testing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza, PromoCell GmbH, American Type Culture Collection, Charles River Laboratories International Inc., Bionique Testing Laboratories Inc., Biological Industries Israel Beit Haemek Ltd., InvivoGen, Agilent Technologies, Abbott, Roche Diagnostics, Boston Scientific Corporation, Clongen Laboratories LLC, Creative Bioarray, Nelson Laboratories Fairfield Inc., Norgen Biotek Corporation, Biotools B & M Labs S.A, GenBio, GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc., AngioDynamics, AtriCure Inc., CONMED Corporation, Olympus Corporation, Smith & Nephew, and Advanced Cardiac Therapeutics.

The global mycoplasma testing market is expected to grow from $0.64 billion in 2020 to $0.72 billion in 2021 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to a growing demand for these type of tests owing to an increase in spread of mycoplasma pneumonia. The market is expected to reach $1.14 billion in 2025 at a CAGR of 12.38%.

The mycoplasma testing market consists of sales of mycoplasma testing services and related products by entities (organizations, sole traders, and partnerships) that provide mycoplasma testing to detect mycoplasma pneumoniae, which causes mycoplasma pneumonia. Mycoplasma pneumonia is a contagious respiratory infection that spreads easily through contact with respiratory fluids. It can cause epidemics. Mycoplasma testing includes a group of tests that measures antibodies in the blood produced in response to a mycoplasma infection and detects the microbe directly through detecting or culturing its genetic material (DNA) in a body sample.

The main types of mycoplasma testing technologies include polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), enzymatic methods, and deoxyribonucleic acid (DNA) staining. Polymerase chain reaction (PCR) detects mycoplasma species using primers specific for mycoplasma DNA, usually mycoplasma 16S rRNA genes. Enzyme-linked immunosorbent assay (ELISA) detects the presence of mycoplasma using either antibodies, or labeled probes for the mycoplasma 16S rRNA genes. Enzymatic methods use a sample of the suspected cell culture which converts ADP to ATP using mycoplasmal enzymes. Deoxyribonucleic acid (DNA) staining detects the mycoplasma strain M. hyorhinis by growing a sample of suspected cell cultures with Vero cells, and staining the cells for DNA using a fluorescent dye. The different products in mycoplasma testing include instruments, assay, kits, and reagents. Mycoplasma testing is applied in cell line testing, virus testing, and end- of- production cell testing and is used by pharmaceutical & biotechnology companies, cell banks & laboratories, contract research organizations, academic research institutes.

North America was the largest region in the mycoplasma testing market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The lack of skilled/trained molecular biologists is expected to restrain the growth of the market in the forecast period. Mycoplasma testing requires specialized skillsets relating to life sciences, pharmaceuticals, electronics and software. These skillsets are available to a limited number of organizations, most of which are located in the USA and Europe. Lack of trained manpower capable of performing the molecular biology experiments and interpreting the results is a major limitation in the testing and confinement of COVID-19 in developing countries. For the few laboratory experts present in these countries, priority is given to other medical emergencies such as heart attacks and road accidents. This shortage of skilled labor is expected to be a significant deterrent to the growth of the market during the forecast period.

In January 2020, Charles River Laboratories International, Inc., a USA-based company specializing in a variety of preclinical and clinical laboratory services for the biotechnology, pharmaceuticals, and medical devices industry acquired HemaCare Corporation for approximately $380 million in cash. With the acquisition, Charles River Laboratories International, Inc. expands the scientific capabilities of the company in the high-growth cell therapy sector and HemaCare cellular products improve Charles River Laboratories ability to offer a comprehensive cell therapy solution, including mycoplasma detection. HemaCare Corporation is a USA-based company engaged in the production of human-derived biological products and services for cellular therapy development, drug discovery, and biomedical research.

The prevalence of mycoplasma pneumonia co-infection among patients with COVID-19 is expected to boost the market for mycoplasma testing in the forecast period. The presence of co-infection of M. pneumonia increases the need to test patients with COVID-19, increasing demand for routine diagnostic tests for respiratory pathogens like M. pneumonia. The coinfections in COVID-19 cases has a significant probability of them being caused by Mycoplasma pneuminiae. For instance, according to a 2020 study published in the Archives of Medical Laboratory Sciences, the co-infection due to M. pneumonia varied between 1 and 40.6% depending on the population and diagnostic tests used and the combined prevalence of M. pneumoniae co-infection among patients with COVID-19 was reported by 17%.

Major players operating in the market are undertaking various strategic investments such as the launch of innovative products, research and development advancements, and technological innovations, which are gaining significant popularity in the mycoplasma testing market. Companies are introducing new innovative products to meet the requirements of end-users and expand the consumer base to survive in the competitive business environment. For instance, in July 2020, bioMérieux, a France-based biotechnology company introduced Bio Fire Mycoplasma, an advanced test used for bio-therapeutics including hormones, antibodies, gene, and cell therapies for mycoplasma detection in pharmaceutical products. In another instance, in March 2019, Lonza, a Switzerland-based chemicals and biotechnology company, launched Lucetta 2 Luminometer to increase the accuracy and speed of mycoplasma detection in cell culture experiments. The luminometer is a single-tube system intended to accelerate and simplify mycoplasma detection in cell cultures.

The countries covered in the Mycoplasma Testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza
  • PromoCell GmbH
  • American Type Culture Collection
  • Charles River Laboratories International Inc.
  • Bionique Testing Laboratories Inc.
  • Biological Industries Israel Beit Haemek Ltd.
  • InvivoGen
  • Agilent Technologies
  • Abbott
  • Roche Diagnostics
  • Boston Scientific Corporation
  • Clongen Laboratories LLC
  • Creative Bioarray
  • Nelson Laboratories Fairfield Inc.
  • Norgen Biotek Corporation
  • Biotools B & M Labs S.A
  • GenBio
  • GeneCopoeia Inc.
  • Minerva Biolabs GmbH
  • Mycoplasma Experience
  • Savyon Diagnostics
  • ScienCell Research Laboratories Inc.
  • AngioDynamics
  • AtriCure Inc.
  • CONMED Corporation
  • Olympus Corporation
  • Smith & Nephew
  • Advanced Cardiac Therapeutics
  • ARTWORKSIT
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll